Ignite Creation Date:
2025-12-18 @ 8:15 AM
Ignite Modification Date:
2025-12-18 @ 8:15 AM
Study NCT ID:
NCT00858923
Status:
None
Last Update Posted:
2009-04-08 00:00:00
First Post:
2009-03-06 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV)
Sponsor:
None
Organization:
Study Overview
Official Title:
Phase 1 Study of the HemoModulator System for the Treatment of Human Immunodeficiency Virus (HIV)
Status:
None
Status Verified Date:
2009-03
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
You may be eligible if:
* You have HIV
* Your CD4 cell count is or greater than 400
* Your viral load is greater than 10,00 copies
* You do not yet qualify for standard antiviral therapy (HAART)
* You have HIV
* Your CD4 cell count is or greater than 400
* Your viral load is greater than 10,00 copies
* You do not yet qualify for standard antiviral therapy (HAART)
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: